Stock listing
ASX:EBR EBR Systems, Inc. Share Price
Home listing (ASX) of EBR Systems, Inc.
Follow EBR Systems, Inc. into a list and get an email when it puts out news.
Share price · ASX:EBR
$0.16 AUD +0.01 (+6.7%)
Close on Nov 20, 2026
- Day range
- $0.155 – $0.185 AUDNov 20, 2026
- Volume
- 2.75M sharesNov 20, 2026
- Market cap
- $120.5M AUDAt the close on Nov 20, 2026 · price × 753.4M shares outstanding
- 52-week range
- $0.105 – $1.14 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $421,837 AUDMedian day 1.56M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:EBR · Home | $0.16 AUD | +0.01 (+6.7%) | 2,751,147 | $0.155 | $0.185 | $0.155 | $0.15 | Close on Nov 20, 2026 |
| OTC:EBRCZ | $0.083 USD | 0.000 (0.0%) | — | $0.083 | $0.083 | $0.083 | $0.083 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:EBR · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.16 | +0.01 | +6.7% | $0.155 | $0.185 | $0.155 | 2,751,147 | |
| $0.15 | -0.015 | -9.1% | $0.165 | $0.165 | $0.145 | 1,501,310 | |
| $0.165 | +0.01 | +6.5% | $0.155 | $0.165 | $0.155 | 448,287 | |
| $0.155 | 0.00 | 0.0% | $0.155 | $0.16 | $0.155 | 761,200 | |
| $0.155 | -0.015 | -8.8% | $0.17 | $0.175 | $0.155 | 2,623,054 | |
| $0.17 | 0.00 | 0.0% | $0.165 | $0.185 | $0.16 | 3,397,037 | |
| $0.17 | +0.005 | +3.0% | $0.16 | $0.17 | $0.155 | 2,969,766 | |
| $0.165 | +0.03 | +22.2% | $0.14 | $0.165 | $0.14 | 3,407,551 | |
| $0.135 | +0.01 | +8.0% | $0.13 | $0.15 | $0.13 | 4,729,061 | |
| $0.125 | +0.005 | +4.2% | $0.12 | $0.125 | $0.115 | 1,329,132 | |
| $0.12 | +0.01 | +9.1% | $0.11 | $0.125 | $0.105 | 3,484,136 | |
| $0.11 | -0.005 | -4.3% | $0.12 | $0.12 | $0.11 | 1,493,021 | |
| $0.115 | 0.00 | 0.0% | $0.115 | $0.12 | $0.11 | 1,484,533 | |
| $0.115 | -0.015 | -11.5% | $0.125 | $0.13 | $0.115 | 1,520,940 | |
| $0.13 | +0.01 | +8.3% | $0.125 | $0.135 | $0.12 | 1,776,431 | |
| $0.12 | -0.01 | -7.7% | $0.125 | $0.135 | $0.12 | 2,077,998 | |
| $0.13 | +0.005 | +4.0% | $0.125 | $0.13 | $0.12 | 1,088,324 | |
| $0.125 | -0.01 | -7.4% | $0.14 | $0.14 | $0.12 | 2,274,784 | |
| $0.135 | 0.00 | 0.0% | $0.14 | $0.14 | $0.13 | 1,113,821 | |
| $0.135 | -0.005 | -3.6% | $0.145 | $0.148 | $0.135 | 1,743,090 | |
| $0.14 | -0.005 | -3.4% | $0.145 | $0.145 | $0.14 | 824,141 | |
| $0.145 | -0.005 | -3.3% | $0.15 | $0.15 | $0.145 | 284,868 | |
| $0.15 | +0.005 | +3.4% | $0.15 | $0.165 | $0.15 | 2,282,970 | |
| $0.145 | +0.005 | +3.6% | $0.145 | $0.15 | $0.14 | 1,365,863 | |
| $0.14 | 0.00 | 0.0% | $0.145 | $0.145 | $0.14 | 1,178,349 | |
| $0.14 | -0.015 | -9.7% | $0.155 | $0.155 | $0.14 | 2,410,309 | |
| $0.155 | 0.00 | 0.0% | $0.165 | $0.165 | $0.155 | 3,767,496 | |
| $0.155 | +0.015 | +10.7% | $0.14 | $0.165 | $0.14 | 7,115,658 | |
| $0.14 | -0.095 | -40.4% | $0.22 | $0.22 | $0.13 | 27,915,201 | |
| $0.235 | +0.005 | +2.2% | $0.235 | $0.245 | $0.235 | 1,298,389 | |
| $0.23 | -0.015 | -6.1% | $0.245 | $0.25 | $0.23 | 1,893,989 | |
| $0.245 | -0.005 | -2.0% | $0.255 | $0.255 | $0.245 | 988,310 | |
| $0.25 | 0.00 | 0.0% | $0.26 | $0.26 | $0.25 | 816,498 | |
| $0.25 | -0.01 | -3.8% | $0.26 | $0.263 | $0.25 | 1,049,341 | |
| $0.26 | -0.02 | -7.1% | $0.275 | $0.275 | $0.26 | 446,435 | |
| $0.28 | 0.00 | 0.0% | $0.28 | $0.28 | $0.28 | 2,385,886 | |
| $0.28 | +0.02 | +7.7% | $0.26 | $0.29 | $0.26 | 1,335,612 | |
| $0.26 | +0.02 | +8.3% | $0.25 | $0.27 | $0.25 | 1,860,092 | |
| $0.24 | -0.005 | -2.0% | $0.25 | $0.255 | $0.24 | 878,100 | |
| $0.245 | -0.005 | -2.0% | $0.255 | $0.26 | $0.245 | 805,328 | |
| $0.25 | -0.015 | -5.7% | $0.263 | $0.265 | $0.25 | 1,609,453 | |
| $0.265 | 0.00 | 0.0% | $0.265 | $0.27 | $0.26 | 671,202 | |
| $0.265 | 0.00 | 0.0% | $0.265 | $0.265 | $0.255 | 937,773 | |
| $0.265 | +0.005 | +1.9% | $0.275 | $0.275 | $0.26 | 1,074,074 | |
| $0.26 | +0.015 | +6.1% | $0.255 | $0.275 | $0.25 | 734,833 | |
| $0.245 | 0.00 | 0.0% | $0.245 | $0.255 | $0.24 | 3,554,271 | |
| $0.245 | 0.00 | 0.0% | $0.25 | $0.25 | $0.235 | 1,929,332 | |
| $0.245 | -0.015 | -5.8% | $0.255 | $0.26 | $0.245 | 2,004,239 | |
| $0.26 | +0.005 | +2.0% | $0.26 | $0.26 | $0.25 | 1,544,565 | |
| $0.255 | -0.02 | -7.3% | $0.27 | $0.27 | $0.25 | 2,850,059 | |
| $0.275 | -0.02 | -6.8% | $0.29 | $0.29 | $0.275 | 1,851,437 | |
| $0.295 | -0.005 | -1.7% | $0.295 | $0.295 | $0.285 | 2,124,924 | |
| $0.30 | +0.015 | +5.3% | $0.295 | $0.30 | $0.285 | 1,081,887 | |
| $0.285 | +0.005 | +1.8% | $0.285 | $0.31 | $0.285 | 2,512,184 | |
| $0.28 | 0.00 | 0.0% | $0.28 | $0.29 | $0.28 | 575,867 | |
| $0.28 | 0.00 | 0.0% | $0.28 | $0.285 | $0.275 | 276,554 | |
| $0.28 | -0.005 | -1.8% | $0.285 | $0.285 | $0.27 | 1,327,220 | |
| $0.285 | +0.01 | +3.6% | $0.28 | $0.29 | $0.28 | 457,987 | |
| $0.275 | 0.00 | 0.0% | $0.275 | $0.285 | $0.27 | 1,115,100 | |
| $0.275 | -0.005 | -1.8% | $0.275 | $0.285 | $0.275 | 2,561,245 | |
| $0.28 | -0.015 | -5.1% | $0.295 | $0.295 | $0.28 | 889,934 | |
| $0.295 | -0.01 | -3.3% | $0.30 | $0.30 | $0.29 | 1,577,241 | |
| $0.305 | +0.02 | +7.0% | $0.285 | $0.305 | $0.28 | 1,727,046 | |
| $0.285 | +0.01 | +3.6% | $0.27 | $0.29 | $0.265 | 2,039,665 | |
| $0.275 | -0.01 | -3.5% | $0.28 | $0.28 | $0.265 | 2,656,724 | |
| $0.285 | +0.01 | +3.6% | $0.275 | $0.29 | $0.275 | 3,038,239 |
- Ticker
- ASX:EBR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 19, 2026
CMS Proposes National Medicare Coverage for WiSE System
Latest deck · Jul 31, 2026
Q2 2026 Earnings Presentation
Earnings · 9 slides
Latest news
CMS Proposes National Medicare Coverage for WiSE System
Nov 19, 2026
Closed $0.16 (+6.7%) on Nov 20, 2026
Change of Director's Interest Notice
Nov 15, 2026
Closed $0.155 (0.0%) on Nov 16, 2026
Customers Notification - Updated Ultrasound Precautions
Nov 11, 2026
Closed $0.17 (0.0%) on Nov 12, 2026
Investor Webinar - Updated
Nov 9, 2026
Closed $0.165 (+22.2%) on Nov 10, 2026
Investor Webinar
Nov 9, 2026
Closed $0.165 (+22.2%) on Nov 10, 2026
Q3 2026 Quarterly Activity Report and Form 10-Q Submission
Nov 9, 2026
Closed $0.165 (+22.2%) on Nov 10, 2026
EBR to Present at Canaccord Genuity Forum
Nov 2, 2026
Closed $0.115 (0.0%) on Nov 3, 2026
Notification of cessation of securities - EBR
Oct 19, 2026
Closed $0.15 (+3.4%) on Oct 20, 2026
EBR Submits TGA ARTG Application for WiSE System
Oct 19, 2026
Closed $0.15 (+3.4%) on Oct 20, 2026
Notification regarding unquoted securities - EBR
Oct 18, 2026
Closed $0.145 (+3.6%) on Oct 19, 2026
EBR Systems, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 36 in the last 12 months · 36 in all · newest Nov 19, 2026 · oldest 2026
- Decks
- 28 decks · latest Jul 31, 2026
Where EBR Systems, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:EBR · Home listing · This page | ASX | Australia | AUD |
| OTC:EBRCZ | OTC | United States | USD |
Valuation
Price/book 1.0× against a median of 1.4×: 5th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $54.64M AUD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.0×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.5×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| EBR Systems, Inc. · ASX:EBR | US$79.78M | US$36.17M | n/a | n/a | n/a | 1.0× | n/a | 0.5× | n/a |
| Viromed Medical AG · XETR:VME | US$83.96M | US$83.66M | 127× | 15.0× | n/a | 8.1× | 11.9% | 0.0× | n/a |
| ICARES Medicus Inc · TPEX:6612 | US$83.86M | US$61.27M | 29.6× | 1.7× | 7.3× | 1.5× | 7.7% | 0.0× | n/a |
| Nyxoah SA · EURONEXT:NYXH | US$83.60M | US$6.53M | n/a | 0.3× | n/a | 0.9× | −443.2% | 0.3× | n/a |
| Optiscan Imaging Limited · ASX:OIL | US$83.05M | US$74.44M | n/a | 251× | n/a | 6.6× | n/a | 0.1× | n/a |
| DIO Corporation · KRX:039840 | US$78.78M | US$59.85M | 4.8× | 0.5× | 3.4× | 0.6× | 12.7% | 0.1× | n/a |
| Zomedica Corp. · OTC:ZOMDF | US$78.49M | US$71.21M | n/a | 1.8× | n/a | 0.8× | −41.3% | 0.0× | 0.10 |
| SkinHealth Systems Inc. · NASDAQ:SKIN | US$77.00M | US$228.9M | n/a | 0.8× | 8.0× | 1.4× | −6.3% | 4.7× | 1.24 |
| Graphy Inc. · KRX:318060 | US$76.80M | US$76.08M | n/a | 4.4× | n/a | 6.8× | −48.1% | 0.0× | n/a |
| L&K BIOMED Co., Ltd. · KRX:156100 | US$76.55M | US$61.13M | 37.3× | 2.1× | 24.3× | 1.6× | 6.9% | 0.0× | n/a |
| Wellell Inc. · TWSE:4106 | US$73.78M | US$52.11M | 13.1× | 0.7× | 5.4× | 1.0× | 7.4% | 0.1× | n/a |
| Median of the others | US$78.64M | US$66.24M | 29.6× | 1.8× | 7.3× | 1.4× | 6.9% | 0.1× | 0.67 |
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.98 AUD · Analysts' mean
- EPS, year to Dec 2026
- -0.11 · 2 analysts
- Revenue, year to Dec 2026
- 10.55M · 2 analysts
Team and board
| Officer | Role |
|---|---|
| John Smith | CEO |
| Robert C. Canby | Chief Medical Officer |
| Santa Clara | EBR announces transition of Chief Commercial Officer |
| Sara Hardin | Project Manager |
| Simon Adams | CTO |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 11, 2026 · After close | +1.8% |
| Q1 2026 | May 11, 2026 · After close | −12.5% |
| Q4 2025 | Mar 18, 2026 · After close | +1.4% |
| Q3 2025 | Nov 12, 2025 · After close | −4.2% |
| Q2 2025 | Aug 12, 2025 · After close | +3.0% |
| Q1 2025 | May 13, 2025 · After close | −4.2% |
| Q4 2024 | Mar 24, 2025 | −1.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 9 slides | Jul 31, 2026 |
| Investor Presentation (June 2026) | Investor deck | 50 slides | Jun 4, 2026 |
| Shareholder Meeting (May 2026) | Shareholder meeting | 8 slides | May 7, 2026 |
| Investor Presentation (March 2026) | Investor deck | 22 slides | Mar 10, 2026 |
| Piper Sandler 37th Annual Healthcare Conference (December 2025) | Conference | 14 slides | Dec 1, 2025 |
| Drug & Device Conference (October 2025) | Conference | 14 slides | Oct 9, 2025 |
| HealthInvest 2025 | Conference | 13 slides | Sep 22, 2025 |
| Canaccord Growth Conference 2025 | Conference | 14 slides | Aug 11, 2025 |
| Investor Presentation (May 2025) | Investor deck | 47 slides | May 22, 2025 |
| Shareholder Meeting (May 2025) | Shareholder meeting | 10 slides | May 22, 2025 |
All 28 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2025) | Investor deck | 18 slides | Apr 14, 2025 |
| Investor Presentation (March 2025) | Investor deck | 20 slides | Mar 25, 2025 |
| Investor Presentation (January 2025) | Investor deck | 19 slides | Jan 21, 2025 |
| Investor Presentation (September 2024) | Investor deck | 50 slides | Sep 18, 2024 |
| Investor Presentation (July 2024) | Investor deck | 18 slides | Jul 12, 2024 |
| Shareholder Meeting (May 2024) | Shareholder meeting | 9 slides | May 30, 2024 |
| Investor Presentation (January 2024) | Investor deck | 20 slides | Jan 30, 2024 |
| Bell Potter Healthcare Conference 2023 | Conference | 16 slides | Nov 15, 2023 |
| Investor Presentation (June 2023) | Investor deck | 40 slides | Jun 23, 2023 |
| Investor Presentation (May 2023) | Investor deck | 20 slides | May 29, 2023 |
| Shareholder Meeting (May 2023) | Shareholder meeting | 8 slides | May 23, 2023 |
| Investor Presentation (May 2023) | Investor deck | 27 slides | May 22, 2023 |
| Investor Presentation (April 2023) | Investor deck | 18 slides | Apr 26, 2023 |
| Investor Presentation (January 2023) | Investor deck | 18 slides | Jan 30, 2023 |
| Corporate Update (October 2022) | Corporate update | 6 slides | Oct 21, 2022 |
| Shareholder Meeting (May 2022) | Shareholder meeting | 9 slides | May 12, 2022 |
| Investor Presentation (March 2022) | Investor deck | 20 slides | Mar 14, 2022 |
| Investor Presentation (February 2022) | Investor deck | 21 slides | Feb 2, 2022 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of cHESS Depositary Interests (CDIs) Closed: A$35M raised · A$0.38 a share | Aug 25, 2026 | US$25.05M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 1.62M | ||
| Cost of revenue | 1.13M | ||
| Gross profit | 490.0K | ||
| Research and development | 23.9M | 27.1M | 27.1M |
| Operating income | -46.1M | -38.3M | -34.5M |
| Depreciation and amortization | 403.0K | 587.0K | 752.3K |
| EBITDA | -45.7M | -37.7M | -33.8M |
| Interest expense | 5.64M | 6.03M | 4.48M |
| Income before tax | -48.8M | -40.8M | -35.0M |
| Income tax | 2.00K | 2.00K | 1.63K |
| Net income | -48.8M | -40.8M | -35.0M |
| Earnings per share, basic | -0.12 | -0.13 | -0.12 |
| Earnings per share, diluted | -0.12 | -0.13 | -0.12 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and equivalents | 5.79M | 6.92M | 14.6M |
| Short-term investments | 47.4M | 53.7M | 57.7M |
| Inventory | 13.8M | 1.39M | 0 |
| Current assets | 73.1M | 64.5M | 74.4M |
| Property, plant and equipment | 5.48M | 795.0K | 1.09M |
| Total assets | 97.2M | 73.6M | 78.9M |
| Accounts payable | 7.05M | 3.25M | 1.86M |
| Current liabilities | 14.0M | 8.33M | 6.45M |
| Total debt | 41.8M | 41.8M | |
| Total liabilities | 71.6M | 49.2M | 47.8M |
| Shareholders' equity | 25.6M | 24.4M | 31.1M |
| Shares outstanding | 45.0M | 371.1M | 307.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash from operations | -53.2M | -41.2M | -32.7M |
| Capital spending | -3.68M | -273.0K | -354.1K |
| Free cash flow | -56.9M | -41.5M | -33.1M |
| Cash from investing | 7.84M | 1.11M | -8.64M |
| Cash from financing | 46.8M | 32.5M | 40.5M |
| Change in cash | 1.48M | -7.66M | -877.6K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| CMS Proposes National Medicare Coverage for WiSE System | Nov 19, 2026 | Operations update | ASX |
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| Change of Director's Interest Notice | Nov 15, 2026 | Ownership change notice | ASX |
| Customers Notification - Updated Ultrasound Precautions | Nov 11, 2026 | Other filings | ASX |
| Investor Webinar | Nov 9, 2026 | Meeting notice | ASX |
| Q3 2026 Quarterly Activity Report and Form 10-Q Submission | Nov 9, 2026 | Other filings | ASX |
| 10-Q · Quarterly report | Nov 9, 2026 | Quarterly report | SEC |
| EBR to Present at Canaccord Genuity Forum | Nov 2, 2026 | Other filings | ASX |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 2, 2026 | Big-stake notice | SEC |
| Notification of cessation of securities - EBR | Oct 19, 2026 | Financing | ASX |
All 159 filings
Cap table
Built by 6ix from EBR Systems, Inc.’s releases · as of Aug 25, 2026
- Common shares
- 753,355,590
- Fully diluted
- 753,355,590
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 753,355,590 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 753,355,590 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen Drexler Other companies: Outset Medical, Inc. (Director · Since at least Jan 8, 2021); ResMed Inc. (Director · Since at least Nov 16, 2017); Valion Bio, Inc. (Director · Nov 10, 2021 – Sep 30, 2024 · Past) | Director · Since at least Sep 30, 2024 |
| Allan R Will Other companies: Fractyl Health, Inc. (Director · Feb 1, 2024 – Feb 1, 2024 · Past) | Director · Since at least Sep 30, 2024 |
| Trevor J Moody Other companies: electroCore, Inc. (Director · Jun 21, 2018 – Aug 2, 2023 · Past) | Director · Since at least Sep 30, 2024 |
| Bronwyn Evans | Director · Since at least Sep 30, 2024 |
| Christopher Nave | Director · Since at least Sep 30, 2024 |
| David Steinhaus | Director · Since at least Sep 30, 2024 |
| Erik Strandberg | Chief Commercial Officer · Since at least Mar 24, 2025 |
| Gary W Doherty | Chief Financial Officer · Since at least Sep 30, 2024 |
| John McCutcheon | President and CEO, Director · Since at least Sep 30, 2024 |
| John Smith | CEO · Since at least Nov 4, 2026 |
All 15 people
| Person | Seat |
|---|---|
| Michael Hendricksen | Chief Operating Officer · Since at least Sep 30, 2024 |
| Robert C. Canby | Chief Medical Officer · Since at least Oct 16, 2026 |
| Santa Clara | EBR announces transition of Chief Commercial Officer · Since at least Aug 20, 2026 |
| Sara Hardin | Project Manager · Since at least Nov 4, 2026 |
| Simon Adams | CTO · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about EBR Systems, Inc.